Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs
This article was originally published in The Tan Sheet
Executive Summary
Insight Pharmaceutical expanded its women’s health care footprint with the acquisition of the Monistat North American portfolio from McNeil Consumer Healthcare.
You may also be interested in...
J&J Brand Revival Plan Relies On Marketing, Delivery Innovation
Johnson & Johnson expects innovation and marketing to restore consumer confidence in its OTC brands and drive a market-share rebound even as its U.S. sales continue to fall, dropping nearly 25% in its latest quarter.
J&J Consumer Recaptures Growth, Plans To Restore Most OTCs By Mid-2012
Johnson & Johnson reported July 19 the first period of positive growth for its consumer unit in more than a year.